143 related articles for article (PubMed ID: 7967709)
1. Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivo.
Ribrag V; Massaad L; Janot F; Bissery MC; Parise O; Gouyette A; Chabot GG
Leuk Res; 1994 Nov; 18(11):829-35. PubMed ID: 7967709
[TBL] [Abstract][Full Text] [Related]
2. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
3. Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38.
Massaad L; Chabot GG; Toussaint C; Koscielny S; Morizet J; Bissery MC; Gouyette A
Cancer Chemother Pharmacol; 1994; 34(6):497-502. PubMed ID: 7923560
[TBL] [Abstract][Full Text] [Related]
4. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.
Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG
Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260
[TBL] [Abstract][Full Text] [Related]
5. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma.
Janot F; Massaad L; Ribrag V; de Waziers I; Beaune PH; Luboinski B; Parise O; Gouyette A; Chabot GG
Carcinogenesis; 1993 Jul; 14(7):1279-83. PubMed ID: 8330340
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.
Massaad L; de Waziers I; Ribrag V; Janot F; Beaune PH; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1992 Dec; 52(23):6567-75. PubMed ID: 1423302
[TBL] [Abstract][Full Text] [Related]
7. [Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors].
Massaad L; de Waziers I; Ribrag V; Janot F; Morizet J; Beaune PH; Gouyette A; Chabot GG
Bull Cancer; 1993 May; 80(5):397-407. PubMed ID: 8173193
[TBL] [Abstract][Full Text] [Related]
8. Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy.
Ribrag V; Massaad L; Janot F; Morizet J; Gouyette A; Chabot GG
Leuk Lymphoma; 1995 Jul; 18(3-4):303-10. PubMed ID: 8535197
[TBL] [Abstract][Full Text] [Related]
9. Severe depletion of cellular thiols and glutathione-related enzymes of a carmustine-resistant L1210 strain associates with collateral sensitivity to cyclophosphamide.
Institoris E; Tretter L; Gaál D
Cancer Chemother Pharmacol; 1993; 33(1):85-8. PubMed ID: 8269595
[TBL] [Abstract][Full Text] [Related]
10. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver.
el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC
Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821
[TBL] [Abstract][Full Text] [Related]
11. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines.
Ali-Osman F; Stein DE; Renwick A
Cancer Res; 1990 Nov; 50(21):6976-80. PubMed ID: 2208164
[TBL] [Abstract][Full Text] [Related]
12. In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells.
Gorbacheva LB; Kukushkina GV; Durdeva AD; Ponomarenko NA
Neoplasma; 1988; 35(1):3-14. PubMed ID: 3127736
[TBL] [Abstract][Full Text] [Related]
13. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
[TBL] [Abstract][Full Text] [Related]
14. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells.
Smith MT; Evans CG; Doane-Setzer P; Castro VM; Tahir MK; Mannervik B
Cancer Res; 1989 May; 49(10):2621-5. PubMed ID: 2713846
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
16. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
Weber GF; Waxman DJ
Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
[TBL] [Abstract][Full Text] [Related]
17. Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea.
McConnell WR; Kari P; Hill DL
Cancer Chemother Pharmacol; 1979; 2(3):221-3. PubMed ID: 455578
[TBL] [Abstract][Full Text] [Related]
18. [The role of N-nitrosourea-induced changes in the nucleoid structure and activity of repair enzymes in the development of drug resistance in mice with leukemia L1210].
Durdyeva ED; Ponomarenko NA; Kukushkina GV; Gorbacheva LB
Biokhimiia; 1987 Aug; 52(8):1335-43. PubMed ID: 3663767
[TBL] [Abstract][Full Text] [Related]
19. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
20. Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line.
Berhane K; Hao XY; Egyházi S; Hansson J; Ringborg U; Mannervik B
Cancer Res; 1993 Sep; 53(18):4257-61. PubMed ID: 8395980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
